O
0.285
0.00 (-1.11%)
前收盘价格 | 0.289 |
收盘价格 | 0.290 |
成交量 | 197,266 |
平均成交量 (3个月) | 400,786 |
市值 | 20,512,242 |
价格/销量 (P/S) | 35.75 |
股市价格/股市净资产 (P/B) | 0.300 |
52周波幅 | |
利润日期 | 12 May 2025 - 16 May 2025 |
营业利益率 (TTM) | -14,371.05% |
稀释每股收益 (EPS TTM) | -0.370 |
季度收入增长率 (YOY) | -46.50% |
总债务/股东权益 (D/E MRQ) | 21.63% |
流动比率 (MRQ) | 5.32 |
营业现金流 (OCF TTM) | -55.96 M |
杠杆自由现金流 (LFCF TTM) | -29.90 M |
资产报酬率 (ROA TTM) | -30.90% |
股东权益报酬率 (ROE TTM) | -33.88% |
市场趋势
短期 | 中期 | ||
行业 | Biotechnology (US) | 混合的 | 混合的 |
Biotechnology (全球的) | 混合的 | 混合的 | |
股票 | Ovid Therapeutics Inc. | 看涨 | 看跌 |
AIStockmoo 评分
2.1
分析师共识 | 5.0 |
内部交易活动 | NA |
价格波动 | 0.5 |
技术平均移动指标 | 3.5 |
技术振荡指标 | -0.5 |
平均 | 2.13 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action. |
|
部门 | Healthcare |
行业 | Biotechnology |
投资方式 | Small Value |
内部持股比例 | 16.29% |
机构持股比例 | 57.13% |
所有权
姓名 | 日期 | 持有股份 |
---|---|---|
Madison Avenue Partners, Lp | 31 Dec 2024 | 3,722,627 |
Kennedy Capital Management Llc | 31 Dec 2024 | 1,545,387 |
Sio Capital Management, Llc | 31 Dec 2024 | 1,000,000 |
Oconnor, A Distinct Business Unit Of Ubs Asset Management Am | 31 Dec 2024 | 943,416 |
52周波幅 | ||
目标价格波幅 | ||
高 | 4.00 (Oppenheimer, 1,301.54%) | 购买 |
4.00 (BTIG, 1,301.54%) | 购买 | |
中 | 4.00 (1,301.54%) | |
低 | 3.00 (Wedbush, 951.16%) | 购买 |
平均值 | 3.67 (1,185.92%) | |
总计 | 3 购买 | |
平均价格@调整类型 | 0.562 |
公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
---|---|---|---|---|
BTIG | 24 Mar 2025 | 4.00 (1,301.54%) | 购买 | 0.444 |
Wedbush | 12 Mar 2025 | 3.00 (951.16%) | 购买 | 0.500 |
Oppenheimer | 29 Jan 2025 | 4.00 (1,301.54%) | 购买 | 0.741 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。
投资组合